Enzymes are Proteos Biotech’s main differentiating element. All enzymes and therapeutic proteins are produced in recombinant form and purified to meet all pharmaceutical standards.

The research and manufacture of recombinant enzymes make Proteos the leading company in enzymatic technology: it has filed its own patent, “Collagenase G and collagenase H compositions for the treatment of diseases involving alterations of collagen”.

Currently, the recombinant enzymes produced by Proteos Biotech are: Keratinase PB333, Collagenase G PB220, Collagenase H PB220, Lipase PB500 and Hyaluronidase PB300.